GlassScriptPhysician profile
John Paul Bonvillian
NPI 1336677046
$11,210.63
in general payments reported to CMS, 2019-2025
16 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $111 · 2021: $10K · 2022: $594 · 2024: $197 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $319.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Crossroads Orthopedics, LLC | $4,863.49 | 2021 | |
| Arthrex, INC. | $3,092.64 | 2021 | |
| Southtech Orthopedics | $1,200.00 | 2021 | |
| Stryker Corporation | $557.81 | 2020-2025 | Ortholoc 3di |
| Paragon 28, INC. | $534.01 | 2021-2024 | Portfolio |
| Convatec INC. | $178.50 | 2024 | |
| Extremity Medical | $152.30 | 2022 | |
| Zimmer Biomet Holdings, INC. | $150.00 | 2022 | |
| Flower Orthopedics Coporation | $149.45 | 2022 | |
| Integra Lifesciences Corporation | $97.22 | 2021 | |
| Horizon Therapeutics Plc | $84.30 | 2022 | |
| Medartis INC. | $54.06 | 2021 | |
| Depuy Synthes Sales INC. | $34.68 | 2021 | |
| Treace Medical Concepts, INC. | $26.58 | 2022 | |
| Biocomposites INC | $18.96 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $16.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bonvillian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.